Potential options to treat hypertriglyceridaemia

Current Drug Targets

Volumn 10, Issue 4, 2009, Pages 356-362

  Viljoen, Adie ^a   Wierzbicki, Anthony S ^b  

^a LISTER HOSPITAL   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Anti hypertensive therapy; Drug; Hypoglycaemic agent; Insulin resistance; Lipid loweringdrug; Metabolic syndrome; Triglyceride

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENOFIBRATE; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; NICOTINIC ACID; OMEGA 3 FATTY ACID; PIOGLITAZONE; PLACEBO; RIMONABANT; ROSIGLITAZONE; SIBUTRAMINE; TESTOSTERONE; TETRAHYDROLIPSTATIN; THIAZOLIDINE DERIVATIVE;

BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG SELECTIVITY; GLYCEMIC CONTROL; HORMONAL THERAPY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOGONADISM; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW; RISK REDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ANIMALS; ANTI-OBESITY AGENTS; ANTILIPEMIC AGENTS; EXERCISE; HUMANS; HYPERTRIGLYCERIDEMIA; RISK FACTORS; TRIGLYCERIDES;

EID: 65549090390     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945009787846380     Document Type: Review

References (114)

1. Thienpont, L. M., Van, U. K. and De Leenheer, A. P. (2002) Clin. Chim. Acta 323, 73-87.
2. McBride, P. E. (2007) JAMA 298, 336-338.
3. Austin, M. A., McKnight, B., Edwards, K. L., Bradley, C. M., McNeely, M. J., Psaty, B. M., Brunzell, J. D. and Motulsky, A. G. (2000) Circulation 101, 2777-2782.
4. Assmann, G., Schulte, H. and von Eckardstein, E. A. (1996) Am. J. Cardiol. 77, 1179-1184.
5. Austin, M. A., Hokanson, J. E. and Edwards, K. L. (1998) Am. J. Cardiol. 81, 7B-12B.
6. Assmann, G., Schulte, H., Funke, H. and von, E. A. (1998) Eur. Heart J. 19(Suppl M), M8-14.
7. Sarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., Boekholdt, S. M., Khaw, K. T. and Gudnason, V. (2007) Circulation 115, 450-458.
8. Mao, E. Q., Tang, Y. Q. and Zhang, S. D. (2003) World J. Gastroenterol. 9, 2622-2626.
9. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). (2001) JAMA 285, 2486-2497.
10. Mead, J. R., Cryer, A. and Ramji, D. P. (1999) FEBS Lett. 462, 1-6.
11. Brown, M. S. and Goldstein, J. L. (1986) Science 232, 34-47.
12. Preiss-Landl, K., Zimmermann, R., Hammerle, G. and Zechner, R. (2002) Curr. Opin. Lipidol. 13, 471-481.
13. Kern, P. A., Ranganathan, S., Li, C., Wood, L. and Ranganathan, G. (2001) Am. J. Physiol Endocrinol. Metab 280, E745-E751.
14. Savage, D. B., Petersen, K. F. and Shulman, G. I. (2007) Physiol Rev. 87, 507-520.
15. Flegal, K. M., Graubard, B. I., Williamson, D. F. and Gail, M. H. (2007) JAMA 298, 2028-2037.
16. Mokdad, A. H., Bowman, B. A., Ford, E. S., Vinicor, F., Marks, J. S. and Koplan, J. P. (2001) JAMA 286, 1195-1200.
17. Yusuf, S., Reddy, S., Ounpuu, S. and Anand, S. (2001) Circulation 104, 2746-2753.
18. Melnikova, I. and Wages, D. (2006) Nat. Rev. Drug Discov. 5, 369-370.
19. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults - The Evidence Report. National Institutes of Health. (1998) Obes. Res. 6(Suppl 2), 51S-209S.
20. Hansen, D. L., Toubro, S., Stock, M. J., Macdonald, I. A. and Astrup, A. (1999) Int. J. Obes. Relat Metab Disord. 23, 1016-1024.
21. James, W. P., Astrup, A., Finer, N., Hilsted, J., Kopelman, P., Rossner, S., Saris, W. H. and Van Gaal, L. F. (2000) Lancet 356, 2119-2125.
22. Arterburn, D. E., Crane, P. K. and Veenstra, D. L. (2004) Arch. Intern. Med. 164, 994-1003.
23. James, W. P. T. (2005) Eur. Heart J 7(Suppl. L), L44-L48.
24. Hvizdos, K. M. and Markham, A. (1999) Drugs 58, 743-760.
25. Rucker, D., Padwal, R., Li, S. K., Curioni, C. and Lau, D. C. (2007) BMJ 335, 1194-1199.
26. Torgerson, J. S., Hauptman, J., Boldrin, M. N. and Sjostrom, L. (2004) Diabetes Care 27, 155-161.
27. Di, M., V, Bifulco, M. and De, P. L. (2004) Nat. Rev. Drug Discov. 3, 771-784.
28. Cota, D., Marsicano, G., Tschop, M., Grubler, Y., Flachskamm, C., Schubert, M., Auer, D., Yassouridis, A., Thone-Reineke, C., Ortmann, S., Tomassoni, F., Cervino, C., Nisoli, E., Linthorst, A. C., Pasquali, R., Lutz, B., Stalla, G. K. and Pagotto, U. (2003) J. Clin. Invest 112, 423-431.
29. Wierzbicki, A. S. (2006) Int. J. Clin. Pract. 60, 1697-1706.
30. Despres, J. P., Golay, A. and Sjostrom, L. (2005) N. Engl. J. Med. 353, 2121-2134.
31. Scheen, A. J., Finer, N., Hollander, P., Jensen, M. D. and Van Gaal, L. F. (2006) Lancet 368, 1660-1672.
32. Rosenstock, J., Hollander, P., Chevalier, S. and Iranmanesh, A. (2008) Diabetes Care 31, 2169-2176.
33. Wood, S. (2009) Unanimous "No" to Rimonabant: Safety Not Demonstrated, FDA Advisory Panel Says. Medscape,.
34. Jones, D. (2008) Nat. Rev. Drug Discov. 7, 961-962.
35. Sanofi-Aventis (2006) Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes (CRESCENDO).
36. Nissen, S. E., Nicholls, S. J., Wolski, K., Rodes-Cabau, J., Cannon, C. P., Deanfield, J. E., Despres, J. P., Kastelein, J. J., Steinhubl, S. R., Kapadia, S., Yasin, M., Ruzyllo, W., Gaudin, C., Job, B., Hu, B., Bhatt, D. L., Lincoff, A. M. and Tuzcu, E. M. (2008) JAMA 299, 1547-1560.
37. Wierzbicki, A. S. (2008) Int. J. Clin. Pract. 62, 981-987.
38. Eaton, S. B. and Konner, M. (1985) N. Engl. J. Med. 312, 283-289.
39. Booth, F. W., Gordon, S. E., Carlson, C. J. and Hamilton, M. T. (2000) J. Appl. Physiol 88, 774-787.
40. Wierzbicki, A. S. (2007) Diabetes Obes. Metab. (In press).
41. Ginsberg, H. N. (1996) Diabetes 45(Suppl 3), S27-S30.
42. Haffner, S. M., Mykkanen, L., Festa, A., Burke, J. P. and Stern, M. P. (2000) Circulation 101, 975-980.
43. Goldberg, I. J. (2001) J. Clin. Endocrinol. Metab 86, 965-971.
44. Bailey, C. J. and Turner, R. C. (1996) N. Engl. J. Med. 334, 574-579.
45. Wulffele, M. G., Kooy, A., de, Z. D., Stehouwer, C. D. and Gansevoort, R. T. (2004) J. Intern. Med. 256, 1-14.
46. Saenz, A., Fernandez-Esteban, I., Mataix, A., Ausejo, M., Roque, M. and Moher, D. (2005) Cochrane Database Syst. Rev. CD002966.
47. Bolen, S., Feldman, L., Vassy, J., Wilson, L., Yeh, H. C., Marinopoulos, S., Wiley, C., Selvin, E., Wilson, R., Bass, E. B. and Brancati, F. L. (2007) Ann. Intern. Med. 147, 386-399.
48. Huupponen, R. K., Viikari, J. S. and Saarimaa, H. (1984) Diabetes Care 7, 575-578.
49. Howard, B. V., Xiaoren, P., Harper, I., Foley, J. E., Cheung, M. C. and Taskinen, M. R. (1985) Am. J. Med. 79, 78-85.
50. Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R. and Neil, H. A. (2008) N. Engl. J. Med. 359, 1577-1589.
51. Chawla, A., Repa, J. J., Evans, R. M. and Mangelsdorf, D. J. (2001) Science 294, 1866-1870.
52. Staels, B., Schoonjans, K., Fruchart, J. C. and Auwerx, J. (1997) Biochimie 79, 95-99.
53. Deeg, M. A. and Tan, M. H. (2008) PPAR. Res. 2008, 520465.
54. Chappuis, B., Braun, M., Stettler, C., Allemann, S., Diem, P., Lumb, P. J., Wierzbicki, A. S., James, R. and Christ, E. R. (2007) Diabetes Metab Res. Rev. 23, 392-399.
55. Rizzo, M., Christ, E. R., Rini, G. B., Spinas, G. A. and Berneis, K. (2008) Expert. Opin. Pharmacother. 9, 2295-2303.
56. Yki-Jarvinen, H. (2004) N. Engl. J. Med. 351, 1106-1118.
57. Rubenstrunk, A., Hanf, R., Hum, D. W., Fruchart, J. C. and Staels, B. (2007) Biochim. Biophys. Acta 1771, 1065-1081.
58. Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M. and Ridker, P. M. (2007) JAMA 298, 309-316.
59. Freiberg, J. J., Tybjaerg-Hansen, A., Jensen, J. S. and Nordestgaard, B. G. (2008) JAMA 300, 2142-2152.
60. Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefebvre, P. J., Murray, G. D., Standl, E., Wilcox, R. G., Wilhelmsen, L., Betteridge, J., Birkeland, K., Golay, A., Heine, R. J., Koranyi, L., Laakso, M., Mokan, M., Norkus, A., Pirags, V., Podar, T., Scheen, A., Scherbaum, W., Schernthaner, G., Schmitz, O., Skrha, J., Smith, U. and Taton, J. (2005) Lancet 366, 1279-1289.
61. Nissen, S. E. and Wolski, K. (2007) N. Engl. J. Med. 356, 2457-2471.
62. Home, P. D., Pocock, S. J., Beck-Nielsen, H., Gomis, R., Hanefeld, M., Jones, N. P., Komajda, M. and McMurray, J. J. (2007) N. Engl. J. Med. 357, 28-38.
63. Wolf-Maier, K., Cooper, R. S., Banegas, J. R., Giampaoli, S., Hense, H. W., Joffres, M., Kastarinen, M., Poulter, N., Primatesta, P., Rodriguez-Artalejo, F., Stegmayr, B., Thamm, M., Tuomilehto, J., Vanuzzo, D. and Vescio, F. (2003) JAMA 289, 2363-2369.
64. Grimm, R. H., Jr., Flack, J. M., Grandits, G. A., Elmer, P. J., Neaton, J. D., Cutler, J. A., Lewis, C., McDonald, R., Schoenberger, J. and Stamler, J. (1996) JAMA 275, 1549-1556.
65. Kasiske, B. L., Ma, J. Z., Kalil, R. S. and Louis, T. A. (1995) Ann. Intern. Med. 122, 133-141.
66. Appel, L. J. (2002) JAMA 288, 3039-3042.
67. ALLHAT Collaborative Research Group. (2000) JAMA 283, 1967-1975.
68. Weidmann, P. and Gerber, A. (1984) J. Cardiovasc. Pharmacol. 6 (Suppl 1), S260-S268.
69. Spence, J. D., Huff, M. and Barnett, P. A. (2000) Can. J. Clin. Pharmacol. 7, 32-37.
70. Brook, R. D. (2000) Curr. Hypertens. Rep. 2, 370-377.
71. Moser, M. (1990) J. Hypertens. Suppl 8, S9-16.
72. Deshmukh, M., Lee, H. W., McFarlane, S. I. and Whaley-Connell, A. (2008) Curr. Diab. Rep. 8, 214-220.
73. Appel, G. B., Radhakrishnan, J., Avram, M. M., DeFronzo, R. A., Escobar-Jimenez, F., Campos, M. M., Burgess, E., Hille, D. A., Dickson, T. Z., Shahinfar, S. and Brenner, B. M. (2003) Diabetes Care 26, 1402-1407.
74. Inoue, T., Morooka, T., Moroe, K., Ikeda, H. and Node, K. (2007) Horm. Metab Res. 39, 372-376.
75. Sacks, F. M. and Walsh, B. W. (1994) Curr. Opin. Lipidol. 5, 236-240.
76. Bittner, V. (2005) J. Am. Coll. Cardiol. 46, 1628-1635.
77. Brunzell, J. D. (2007) N. Engl. J. Med. 357, 1009-1017.
78. Whitsel, E. A., Boyko, E. J., Matsumoto, A. M., Anawalt, B. D. and Siscovick, D. S. (2001) Am. J. Med. 111, 261-269.
79. Ooi, T. C., Heinonen, T., Alaupovic, P., Davignon, J., Leiter, L., Lupien, P. J., Sniderman, A. D., Tan, M. H., Tremblay, G., Sorisky, A., Shurzinske, L. and Black, D. M. (1997) Arterioscler. Thromb. Vasc. Biol. 17, 1793-1799.
80. Stein, E. A., Lane, M. and Laskarzewski, P. (1998) Am. J Cardiol. 81, 66B-69B.
81. Wierzbicki, A. S., Lumb, P. J., Chik, G. and Crook, M. A. (2000) Am. J. Cardiol. 86, 547-9, A9.
82. Baigent, C., Keech, A., Kearney, P. M., Blackwell, L., Buck, G., Pollicino, C., Kirby, A., Sourjina, T., Peto, R., Collins, R. and Simes, R. (2005) Lancet 366, 1267-1278.
83. Staels, B., Dallongeville, J., Auwerx, J., Schoonjans, K., Leitersdorf, E. and Fruchart, J. C. (1998) Circulation 98, 2088-2093.
84. Lambert, G., Jarnoux, A. L., Pineau, T., Pape, O., Chetiveaux, M., Laboisse, C., Krempf, M. and Costet, P. (2006) Endocrinology 147, 4985-4995.
85. Wierzbicki, A. S. (2006) Int. J. Clin. Pract. 60, 442-449.
86. Saha, S. A., Kizhakepunnur, L. G., Bahekar, A. and Arora, R. R. (2007) Am. Heart J. 154, 943-953.
87. Rubins, H. B. (2000) J. Cardiovasc. Risk 7, 339-345.
88. Robins, S. J., Collins, D., Wittes, J. T., Papademetriou, V., Deedwania, P. C., Schaefer, E. J., McNamara, J. R., Kashyap, M. L., Hershman, J. M., Wexler, L. F. and Rubins, H. B. (2001) JAMA 285, 1585-1591.
89. Viljoen, A. (2009) Int. J. Clin. Pract. 63, 3-6.
90. Carlson, L. A. (2005) J. Intern. Med. 258, 94-114.
91. Guyton, J. R. (2004) Expert. Opin. Pharmacother. 5, 1385-1398.
92. Shepherd, J., Betteridge, J. and Van, G. L. (2005) Curr. Med. Res. Opin. 21, 665-682.
93. Kamanna, V. S. and Kashyap, M. L. (2007) Am. J. Cardiol. 100, S53-S61.
94. Kamanna, V. S. and Kashyap, M. L. (2008) Am. J. Cardiol. 101, 20B-26B.
95. Lamon-Fava, S., Diffenderfer, M. R., Barrett, P. H., Buchsbaum, A., Nyaku, M., Horvath, K. V., Asztalos, B. F., Otokozawa, S., Ai, M., Matthan, N. R., Lichtenstein, A. H., Dolnikowski, G. G. and Schaefer, E. J. (2008) Arterioscler. Thromb. Vasc. Biol. 28, 1672-1678.
96. Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J. and Friedewald, W. (1986) J. Am. Coll. Cardiol. 8, 1245-1255.
97. Canner, P. L., Furberg, C. D. and McGovern, M. E. (2006) Am. J. Cardiol. 97, 477-479.
98. McKenney, J. M. and Sica, D. (2007) Pharmacotherapy 27, 715-728.
99. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (1999) Lancet 354, 447-455.
100. Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., Kita, T., Kitabatake, A., Nakaya, N., Sakata, T., Shimada, K. and Shirato, K. (2007) Lancet 369, 1090-1098.
101. Wierzbicki, A. S. (2008) Int. J. Clin. Pract. 62, 1142-1146.
102. Mikhailidis, D. P., Wierzbicki, A. S., Daskalopoulou, S. S., Al-Saady, N., Griffiths, H., Hamilton, G., Monkman, D., Patel, V., Pittard, J. and Schachter, M. (2005) Curr. Med. Res. Opin. 21, 959-969.
103. Mikhailidis, D. P., Sibbring, G. C., Ballantyne, C. M., Davies, G. M. and Catapano, A. L. (2007) Curr. Med. Res. Opin. 23, 2009-2026.
104. Wierzbicki, A. S. (2004) Int. J. Clin. Pract. 58, 1063-1072.
105. Barter, P. and Ginsberg, H. N. (2008) Am. J. Cardiol. 102, 1040-1045.
106. Brown, B. G., Zhao, X. Q., Chait, A., Fisher, L. D., Cheung, M. C., Morse, J. S., Dowdy, A. A., Marino, E. K., Bolson, E. L., Alaupovic, P., Frohlich, J. and Albers, J. J. (2001) N. Engl. J Med 345, 1583-1592.
107. Birjmohun, R. S., Kastelein, J. J., Poldermans, D., Stroes, E. S., Hostalek, U. and Assmann, G. (2007) Curr. Med. Res. Opin. 23, 1707-1713.
108. Wierzbicki, A. S., Mikhailidis, D. P., Wray, R., Schacter, M., Cramb, R., Simpson, W. G. and Byrne, C. B. (2003) Curr. Med. Res. Opin. 19, 155-168.
109. Filippatos, T. D., Kiortsis, D. N., Liberopoulos, E. N., Georgoula, M., Mikhailidis, D. P. and Elisaf, M. S. (2005) Curr. Med. Res. Opin. 21, 1997-2006.
110. Wierzbicki, A. S. (2006) Int. J. Clin. Pract. 60, 1149-1153.
111. Athyros, V. G., Kakafika, A. I., Wierzbicki, A. S., Karagiannis, A. and Mikhailidis, D. P. (2009) Int. J. Clin. Pract. 63, 15-18.
112. Wierzbicki, A. S. (2006) Int. J Clin. Pract. 60, 1149-1153.
113. Baigent, C., Keech, A., Kearney, P. M., Blackwell, L., Buck, G., Pollicino, C., Kirby, A., Sourjina, T., Peto, R., Collins, R. and Simes, R. (2005) Lancet 366, 1267-1278.
114. The Coronary Drug Project Research Group (1975) JAMA 231, 360-381.